Chaparral Labs
back to search

protein

Adipogenesis regulatory factor

ADIRF
protein:Q15847disease:adad:direction:up

Gene

ADIRF

Organism

Homo sapiens(9606)

Length

76 aa

Mass

7,855 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

Adipogenesis regulatory factor (ADIRF) is a small 76-amino acid protein that promotes fat cell development by stimulating transcription of master adipogenesis regulators such as PPARG and CEBPA during preadipocyte differentiation (UniProt: Q15847). The protein has also been noted to confer resistance to the chemotherapeutic agent cisplatin when overexpressed. Its primary known function centers on metabolic regulation during adipogenic lineage commitment.

UniProt records no direct disease associations for ADIRF in their curated database. However, tissue-level expression and metabolic regulatory roles suggest potential relevance to conditions involving lipid metabolism and cellular stress responses.

ADIRF shows upregulation in Alzheimer's disease brain tissue, with a mean log2-fold change of +0.784 across three subcellular fractions in post-mortem AD brain compared to age-matched controls (Chaparral AD proteomics). This upregulation was detected via TMT-labeled quantitative proteomics across four subcellular fractions, though the modest effect size and tissue-level measurement warrant further investigation to determine functional significance in AD pathology.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↑ Up in AD

P3

not detected

P2

+0.991

S2

+0.858

S3

+0.504

Mean log₂FC across detected fractions: +0.784 (3 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

Plays a role in fat cell development; promotes adipogenic differentiation and stimulates transcription initiation of master adipogenesis factors like PPARG and CEBPA at early stages of preadipocyte differentiation. Its overexpression confers resistance to the anticancer chemotherapeutic drug cisplatin

Sources

Last updated 5/8/2026, 6:36:42 AM